美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

NewLink Genetics Corp.

0.8900

0.0000

成交量：- -

成交额：- -

市值：3,319.70万

市盈率：-0.77

高：0.8900

开：0.8900

低：0.8900

收：0.8900

52周最高：3.60

52周最低：0.8403

股本：3,730.00万

流通股本：2,285.43万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.1500

每股收益(LYR):-1.1527

净资产收益率：-44.31%

总资产收益率：-21.70%

市净率：0.42

市盈率(LYR):-0.77

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

NewLink Genetics Corp.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.newlinkgenetics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NLNK/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"NLNK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","market":"US","secType":"STK","nameCN":"NewLink Genetics Corp.","latestPrice":0.89,"timestamp":1584561600000,"preClose":0.89,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":22854328,"shares":37300000,"eps":-1.15,"marketStatus":"盘后交易","change":0,"latestTime":"03-26 17:59:30 EDT","open":0.89,"high":0.89,"low":0.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.15,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"symbolChange":{"newSymbol":"LUMO","executeDate":"2020-03-19"},"adr":0,"adrRate":0,"listingDate":1320987600000,"exchange":"NASDAQ","adjPreClose":0.89,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","floatShares":22854328,"roa":"-21.70%","roe":"-44.31%","lyrEps":-1.152689,"shares":37300000,"dividePrice":0,"high":0.89,"amplitude":0,"preClose":0.89,"low":0.89,"week52Low":0.8403,"pbRate":"0.42","week52High":3.6,"institutionHeld":0,"latestPrice":0.89,"eps":-1.15,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.15,"open":0.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLNK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-19","symbol":"NLNK","oldSymbol":"NLNK","newSymbol":"LUMO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584590400000},{"market":"US","date":"2020-03-19","symbol":"NLNK","type":"split","dateTimestamp":1584590400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2020-02-28","symbol":"NLNK","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盘前","type":"earning","dateTimestamp":1582866000000,"reportTimeType":"pre","actualEps":-1.98},{"date":"2019-11-06","symbol":"NLNK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.27,"defaultRemindTime":1573030800000,"name":null,"time":"盘前","dateTimestamp":1573016400000,"actualEps":null},{"market":"US","date":"2019-05-08","symbol":"NLNK","fiscalQuarterEnding":"2019/03","expectedEps":-0.31,"name":null,"time":"盘后","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLNK\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newlinkgenetics.com","stockEarnings":[{"period":"1week","weight":-0.8889},{"period":"1month","weight":-0.8889},{"period":"3month","weight":-0.8889},{"period":"6month","weight":-0.8889},{"period":"1year","weight":-0.8889},{"period":"ytd","weight":-0.8889}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。","exchange":"NASDAQ","name":"NewLink Genetics Corp.","nameEN":"NewLink Genetics Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":null}}